RhumbLine Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$936M Sell
3,829,150
-144,855
-4% -$33.7M 0.8% 15
2025
Q4
$822M Sell
3,974,005
-64,082
-2% -$12.7M 0.66% 17
2025
Q3
$749M Sell
4,038,087
-24,342
-0.6% -$4.17M 0.6% 21
2025
Q2
$621M Sell
4,062,429
-95,647
-2% -$14.7M 0.53% 21
2025
Q1
$690M Sell
4,158,076
-56,456
-1% -$8.83M 0.65% 22
2024
Q4
$610M Sell
4,214,532
-31,009
-0.7% -$4.81M 0.55% 22
2024
Q3
$688M Sell
4,245,541
-123,776
-3% -$19.7M 0.62% 20
2024
Q2
$639M Buy
4,369,317
+36,268
+0.8% +$5.39M 0.6% 20
2024
Q1
$685M Buy
4,333,049
+56,157
+1% +$8.94M 0.66% 18
2023
Q4
$670M Sell
4,276,892
-18,066
-0.4% -$2.77M 0.7% 18
2023
Q3
$669M Sell
4,294,958
-350,469
-8% -$57.8M 0.78% 16
2023
Q2
$769M Buy
4,645,427
+42,415
+0.9% +$6.85M 0.86% 14
2023
Q1
$713M Buy
4,603,012
+36,210
+0.8% +$5.85M 0.88% 14
2022
Q4
$807M Buy
4,566,802
+177,102
+4% +$30.6M 1.08% 9
2022
Q3
$717M Buy
4,389,700
+247,673
+6% +$41.9M 1.07% 9
2022
Q2
$735M Buy
4,142,027
+203,201
+5% +$36.2M 1.07% 9
2022
Q1
$698M Buy
3,938,826
+80,426
+2% +$13.7M 0.9% 11
2021
Q4
$660M Buy
3,858,400
+53,475
+1% +$8.75M 0.81% 13
2021
Q3
$614M Sell
3,804,925
-180,788
-5% -$30.8M 0.83% 12
2021
Q2
$657M Sell
3,985,713
-201,330
-5% -$33.3M 0.86% 12
2021
Q1
$688M Sell
4,187,043
-230,071
-5% -$37.2M 0.93% 10
2020
Q4
$695M Buy
4,417,114
+15,297
+0.3% +$2.26M 0.96% 11
2020
Q3
$655M Sell
4,401,817
-2,892
-0.1% -$428K 1.03% 8
2020
Q2
$619M Buy
4,404,709
+132,068
+3% +$19.2M 1.03% 9
2020
Q1
$560M Buy
4,272,641
+12,967
+0.3% +$1.84M 1.17% 8
2019
Q4
$621M Sell
4,259,674
-11,637
-0.3% -$1.58M 1.04% 9
2019
Q3
$553M Buy
4,271,311
+72,582
+2% +$9.56M 1.01% 9
2019
Q2
$585M Sell
4,198,729
-103,617
-2% -$14.3M 1.1% 7
2019
Q1
$601M Sell
4,302,346
-83,333
-2% -$11.2M 1.16% 9
2018
Q4
$566M Buy
4,385,679
+58,932
+1% +$8.22M 1.23% 6
2018
Q3
$598M Sell
4,326,747
-84,329
-2% -$11.2M 1.15% 9
2018
Q2
$535M Sell
4,411,076
-31,341
-0.7% -$3.91M 1.08% 10
2018
Q1
$569M Sell
4,442,417
-33,469
-0.7% -$4.52M 1.19% 8
2017
Q4
$625M Buy
4,475,886
+105,104
+2% +$14.6M 1.27% 8
2017
Q3
$568M Buy
4,370,782
+53,585
+1% +$7.1M 1.24% 8
2017
Q2
$571M Sell
4,317,197
-60,100
-1% -$7.67M 1.3% 6
2017
Q1
$545M Buy
4,377,297
+135,573
+3% +$16.2M 1.27% 7
2016
Q4
$489M Buy
4,241,724
+133,188
+3% +$15.4M 1.24% 6
2016
Q3
$485M Buy
4,108,536
+166,794
+4% +$20.2M 1.34% 5
2016
Q2
$478M Buy
3,941,742
+225,436
+6% +$25.6M 1.42% 4
2016
Q1
$402M Buy
3,716,306
+145,646
+4% +$15.1M 1.25% 4
2015
Q4
$367M Sell
3,570,660
-11,439
-0.3% -$1.15M 1.18% 5
2015
Q3
$334M Buy
3,582,099
+57,437
+2% +$5.56M 1.14% 5
2015
Q2
$344M Sell
3,524,662
-686,513
-16% -$68.7M 1.09% 6
2015
Q1
$424M Sell
4,211,175
-52,590
-1% -$5.35M 1.22% 5
2014
Q4
$446M Sell
4,263,765
-64,077
-1% -$6.75M 1.3% 5
2014
Q3
$461M Sell
4,327,842
-83,185
-2% -$8.63M 1.39% 5
2014
Q2
$461M Sell
4,411,027
-55,963
-1% -$5.66M 1.35% 5
2014
Q1
$439M Sell
4,466,990
-114,020
-2% -$10.6M 1.3% 5
2013
Q4
$420M Sell
4,581,010
-190,166
-4% -$17.5M 1.24% 7
2013
Q3
$414M Sell
4,771,176
-17,641
-0.4% -$1.58M 1.28% 6
2013
Q2
$411M Buy
+4,788,817
New +$406M 1.32% 6

Other funds holding JNJ

RhumbLine Advisers's JNJ Position: Q1 2026 in Review

RhumbLine Advisers reduced its Johnson & Johnson (JNJ) stake by 3.6% in Q1 2026, selling an estimated $33.7M and leaving 3,829,150 shares worth $936M. The position accounts for 0.8% of the portfolio, ranked #15.

RhumbLine Advisers first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • RhumbLine Advisers held 3,829,150 shares of Johnson & Johnson worth $936M as of Q1 2026.
  • RhumbLine Advisers sold 144,855 Johnson & Johnson shares in Q1 2026, an estimated $33.7M.
  • Johnson & Johnson made up 0.8% of RhumbLine Advisers's portfolio in Q1 2026, its #15 holding.
  • RhumbLine Advisers first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.